Company Filing History:
Years Active: 2010-2012
Title: André Delhon: Innovator in Cardiovascular Treatments
Introduction
André Delhon is a notable inventor based in Castres, France. He has made significant contributions to the field of cardiovascular health through his innovative research and patents. With a total of 3 patents, Delhon's work focuses on the development of docosahexaenoic acid esters and their applications in medical treatments.
Latest Patents
One of Delhon's latest patents involves DHA esters and their use in the treatment and prevention of cardiovascular disease. This invention relates to a docosahexaenoic acid ester combined with an alcohol selected from the group of B vitamins or provitamins. The patent outlines various formulations, including nicotinyl alcohol, panthenol, and inositol, as well as isosorbide and isosorbide mononitrate. The invention also details a method for preparing these esters, a pharmaceutical composition containing them, and their application in treating conditions such as auricular fibrillation.
Career Highlights
André Delhon is currently associated with Pierre Fabre Medicament, a company known for its commitment to pharmaceutical innovation. His work at this institution has allowed him to focus on developing effective treatments for cardiovascular diseases, contributing to advancements in medical science.
Collaborations
Throughout his career, Delhon has collaborated with esteemed colleagues such as Jean Gardette and Jean François Patoiseau. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.
Conclusion
André Delhon's contributions to the field of cardiovascular health through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, particularly in the prevention and management of cardiovascular diseases.